Midterm Clinical and Angiographic Follow-Up for the First Food and Drug Administration-Approved Pros...
Midterm Clinical and Angiographic Follow-Up for the First Food and Drug Administration-Approved Prospective, Single-Arm Trial of Primary Stenting for Stroke: SARIS (Stent-Assisted Recanalization for Acute Ischemic Stroke)
About this item
Full title
Author / Creator
Publisher
Hagerstown, MD: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Hagerstown, MD: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Abstract
BACKGROUND:
Although early data demonstrate encouraging angiographic results following intracranial stent deployment for acute ischemic stroke, longer-term follow-up is necessary to evaluate the clinical outcomes, as well as the durability of angiographic results.
OBJECTIVE:
We report 6-month clinical and radiologic follow-up d...
Alternative Titles
Full title
Midterm Clinical and Angiographic Follow-Up for the First Food and Drug Administration-Approved Prospective, Single-Arm Trial of Primary Stenting for Stroke: SARIS (Stent-Assisted Recanalization for Acute Ischemic Stroke)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_889446805
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_889446805
Other Identifiers
ISSN
0148-396X
E-ISSN
1524-4040
DOI
10.1227/NEU.0b013e318222afd1
